ImmunocoreIMCR

那斯達克 · USD
32.99
+0.22
(+0.67%)
收盤 08/02 03:59 (UTC+8)
盤後 
(0%)
08/02 03:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • 0.48
  • 0.55
  • 0.48
  • 0.65
  • 0.74
  • 0.71
  • 0.75
  • 0.80
  • 0.84
  • 0.94
icon
  • 16.66
  • 13.73
  • -12.61
  • 35.77
  • 14.09
  • -33.26
  • 6.95
  • 6.43
  • 4.74
  • 11.69
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
2023/Q2
2023/Q1
2022/Q4
營業收入淨額
93,881
84,052
80,248
75,400
70,502
73,987
64,850
47,764
54,659
48,062
營業成本
8313304481,707246-530276886216109
營業毛利
93,050
83,722
79,800
73,693
70,256
74,517
64,574
46,878
54,443
47,953
營業費用
96,666103,17488,302-96,74692,98678,71864,77669,13945,939
研發費用
56,46860,85052,77051,07257,45955,08543,24928,76736,57227,138
推銷及管理費用
40,19842,32435,53238,63839,28737,90235,46936,00932,56721,914
非經常性項目費用
----------
其他營業費用
----------2
營業利益
-3,616
-19,452
-8,502
-16,017
-26,490
-18,470
-14,144
-17,898
-14,696
2,014
其他收入及費用
12,7251,66918,88510,1645,650-----
利息費用
3,0257,0384,2904,2773,239-7231,3211,5651,2501,784
稅前純益
6,084
-24,821
6,093
-10,130
-24,079
-25,962
731
-13,926
-19,156
-23,074
所得稅
1,061-1,050-2,6431,486357-5,899-1751512932,129
稅後純益
5,023
-23,771
8,736
-11,616
-24,436
-20,063
906
-14,077
-19,449
-25,203
基本每股稅後盈餘(元)
0.10-0.470.17-0.23-0.49-0.02-0.35-0.40-0.54
稀釋每股稅後盈餘(元)
0.10-0.470.17-0.23-0.49-0.02-0.35-0.40-0.54
基本平均股數(千股)
50086.0050046.0050021.0050014.0049877.00-49134.0048694.0048183.0046672.00
稀釋平均股數(千股)
51949.0050046.0052808.0050014.0049877.00-54158.0048694.0048183.0046672.00
還原基本每股稅後盈餘(元)
0.10-0.470.17-0.23-0.49-0.02-0.35-0.40-0.54
還原稀釋每股稅後盈餘(元)
0.10-0.470.17-0.23-0.49-0.02-0.35-0.40-0.54
還原基本平均股數(千股)
50,08650,04650,02150,01449,877-49,13448,69448,18346,672
還原稀釋平均股數(千股)
51,94950,04652,80850,01449,877-54,15848,69448,18346,672
EBITDA(千元)
9,963-16,61711,418-4,861-19,829-27,4383,129-10,712-16,954-19,953

大家都在看

HOT